RecruitingNot ApplicableNCT03824145

Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer

Sponsor

Medical College of Wisconsin

Enrollment

176 participants

Start Date

Nov 1, 2022

Study Type

INTERVENTIONAL

Conditions

Metastatic Breast Cancer

Summary

This multi-site study is being conducted to examine dietary and activity patterns, body composition, blood and quality of life in breast cancer patients. The study will recruit 176 women with MBC in Milwaukee (n=88) and Chicago (n=88).

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing a mobile phone-based lifestyle program designed to help women with metastatic breast cancer (cancer that has spread to other parts of the body) become more physically active and improve their overall quality of life. **You may be eligible if...** - You are a woman aged 18 or older - You have confirmed metastatic breast cancer - Your cancer is currently stable (no significant new symptoms, weight loss, or disease progression in the past 4 weeks) - Your life expectancy is more than 6 months - You own a mobile phone - You speak and understand English fluently - You are currently not meeting physical activity guidelines - Your oncologist has given written permission for you to participate **You may NOT be eligible if...** - Your cancer is currently progressing or your health is unstable - You do not have a mobile phone - You have severe, uncontrolled pain - You do not speak English Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALLifestyle Intervention

The lifestyle intervention is a 16-week cognitive-behavioral intervention that addresses key changes in diet and PA behaviors to promote positive body composition changes.

BEHAVIORALAttention Control

The attention control participants will receive a home/work organization intervention: Following completion of the attention control home/work organization program and 16-week assessment, women will receive the lifestyle program.

Locations(2)

Loyola University

Maywood, Illinois, United States

Medical College of Wisconsin

Milwaukee, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03824145

Related Trials

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

NCT066782697 locations

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

NCT0612028363 locations

Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

NCT072527263 locations

Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer

NCT069046251 location

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

NCT06324357108 locations